Cargando…

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions

Vast numbers of differentially expressed genes and perturbed networks have been identified in Alzheimer’s disease (AD), however, neither disease nor brain region specificity of these transcriptome alterations has been explored. Using RNA-Seq data from 231 temporal cortex and 224 cerebellum samples f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xue, Allen, Mariet, İş, Özkan, Reddy, Joseph S., Tutor-New, Frederick Q., Castanedes Casey, Monica, Carrasquillo, Minerva M., Oatman, Stephanie R., Min, Yuhao, Asmann, Yan W., Funk, Cory, Nguyen, Thuy, Ho, Charlotte C.G., Malphrus, Kimberly G., Seyfried, Nicholas T., Levey, Allan I., Younkin, Steven G., Murray, Melissa E., Dickson, Dennis W., Price, Nathan D., Golde, Todd E., Ertekin-Taner, Nilüfer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759790/ https://www.ncbi.nlm.nih.gov/pubmed/34813500 http://dx.doi.org/10.1172/JCI149904

Ejemplares similares

Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
por: Allen, Mariet, et al.
Publicado: (2018)

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
por: Min, Yuhao, et al.
Publicado: (2023)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
por: Li, Hong‐Dong, et al.
Publicado: (2021)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
por: Reddy, Joseph S., et al.
Publicado: (2021)

Clinical Deep Phenotyping of ABCA7 Mutation Carriers
por: Campbell, Alana S., et al.
Publicado: (2022)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

Late-onset Alzheimer disease risk variants mark brain regulatory loci
por: Allen, Mariet, et al.
Publicado: (2015)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
por: Allen, Mariet, et al.
Publicado: (2016)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbations
por: Patel, Tulsi, et al.
Publicado: (2022)

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies
por: Wickland, Daniel P., et al.
Publicado: (2021)

Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy
por: Levites, Yona, et al.
Publicado: (2021)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
por: Oatman, Stephanie R., et al.
Publicado: (2023)

Comparative evaluation for the globin gene depletion methods for mRNA sequencing using the whole blood-derived total RNAs
por: Jang, Jin Sung, et al.
Publicado: (2020)

Microglia show differential transcriptomic response to Aβ peptide aggregates ex vivo and in vivo
por: McFarland, Karen N, et al.
Publicado: (2021)

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012)

Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight
por: Ebbert, Mark T. W., et al.
Publicado: (2019)

Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease
por: Ertekin-Taner, Nilüfer
Publicado: (2011)

Genetics of Alzheimer disease in the pre- and post-GWAS era
por: Ertekin-Taner, Nilüfer
Publicado: (2010)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological study
por: Parker, Matthew J S, et al.
Publicado: (2018)

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
por: Allen, Mariet, et al.
Publicado: (2012)

Identification of missing variants by combining multiple analytic pipelines
por: Ren, Yingxue, et al.
Publicado: (2018)

Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
por: Chung, Jaeyoon, et al.
Publicado: (2018)

Feasibility study of mobile phone photography as a possible outcome measure of systemic sclerosis-related digital lesions
por: Davison, Adrian K, et al.
Publicado: (2022)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression
por: Belbin, Olivia, et al.
Publicado: (2011)

MAPT haplotype–stratified GWAS reveals differential association for AD risk variants
por: Strickland, Samantha L., et al.
Publicado: (2020)

TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
por: Chakrabarty, Paramita, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_amtgfavs4li62pverd9qeq45or